Tasso Celebrates Two Million Device Milestone

Written By Dina Schneider

With two million devices sold, Tasso is now reaching more patients than ever worldwide. Learn how Tasso is making an impact in the infographic below.

 
Dina Schneider
Previous

Neurogen Biomarking Enters Partnership Agreement with Tasso to Bring Virtually Painless Blood Collection Technology to Its Alzheimer’s Testing Platform
Next

Tasso, Inc. Joint Venture Receives Controlled Medical Device Approval in Japan for Novel Self-Administered Blood Collection Device